Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. CK Life Sciences Int'l., (Holdings) Inc.
  6. News
  7. Summary
    775   KYG2176J1058

CK LIFE SCIENCES INT'L., (HOLDINGS) INC.

(775)
  Report
Delayed Hong Kong Stock Exchange  -  03:08:03 2023-01-27 am EST
0.8100 HKD   +1.25%
2022XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development opening a new paradigm for scientific innovation
AQ
2022XtalPi Inc. and CK Life Sciences to Collaborate in Ai-Empowered Tumour Vaccine Research and Development, Opening A New Paradigm for Scientific Innovation
CI
2022CK Life Sciences Int'l., Inc. Announces Retirement of Independent Non-Executive Director and Change in Composition of the Remuneration Committee
CI
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

CK LIFE SCIENCES INT'L., (HOLDINGS) INC. : Ex-dividend day for final dividend

05/20/2022 EST
share with twitter
share with LinkedIn
share with facebook

A final dividend is removed today from CK Life Sciences Int'l., (Holdings) Inc.'s share.



© Factset 2022
All news about CK LIFE SCIENCES INT'L., (HOLDINGS) INC.
2022XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and ..
AQ
2022XtalPi Inc. and CK Life Sciences to Collaborate in Ai-Empowered Tumour Vaccine Research..
CI
2022CK Life Sciences Int'l., Inc. Announces Retirement of Independent Non-Executive Directo..
CI
2022CK Life Sciences' H1 Profit Down 35%
MT
2022CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30,..
CI
2022CK Life Sciences Investors Acquire Stake in Pharus for $5.5 Million Each
MT
2022CK LIFE SCIENCES INT'L., (HOLDINGS) INC. : Ex-divid..
FA
2022CK Life Sciences Int'l., Inc. Announces Ordinary Final Cash Dividend for the Year Ended..
CI
2022CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December..
CI
2022CK Life Sciences Int'l., Inc. acquired Gale Road vineyard.
CI
More news
Financials
Sales 2021 5 402 M 690 M 690 M
Net income 2021 163 M 20,8 M 20,8 M
Net Debt 2021 5 311 M 678 M 678 M
P/E ratio 2021 43,8x
Yield 2021 1,35%
Capitalization 7 785 M 994 M 994 M
EV / Sales 2020 2,77x
EV / Sales 2021 2,30x
Nbr of Employees 1 829
Free-Float 25,0%
Chart CK LIFE SCIENCES INT'L., (HOLDINGS) INC.
Duration : Period :
CK Life Sciences Int'l., (Holdings) Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CK LIFE SCIENCES INT'L., (HOLDINGS) INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Managers and Directors
Ying Choi Yu Chief Operating Officer & Vice President
Hing Lam Kam President & Executive Director
Yiu Leung Mo Chief Financial Officer
Tzar Kuoi Li Chairman
Kean Meng Toh Executive Director, Chief Scientific Officer & VP
Sector and Competitors
1st jan.Capi. (M$)
CK LIFE SCIENCES INT'L., (HOLDINGS) INC.1.27%982
ZHEJIANG NHU COMPANY LTD.4.11%8 845
BY-HEALTH CO., LTD.5.39%6 029
BALCHEM CORPORATION5.95%4 157
BELLRING BRANDS, INC.7.02%3 715
THE SIMPLY GOOD FOODS COMPANY-5.68%3 568